Get started
RocketTickers

AbbVie Announces Patient-Reported Outcomes Data from Three Pivot

Long
AbbVie Inc. (NYSE:ABBV)  
RocketTickers  
NYSE:ABBV   AbbVie Inc.
Beyond Technical Analysis
2
0
beyondta
ABBV: AbbVie
2018-09-13 06:20:00
AbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.